Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Magnesium Citrate Dibasic, Anhydrous
2. 144-23-0
3. 7779-25-1
4. Magnesiumcitrate(x:1)
5. Magnesium Citrate(x:1)
6. Akos028109527
7. J-007935
Molecular Weight | 214.41 g/mol |
---|---|
Molecular Formula | C6H6MgO7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 3 |
Exact Mass | 213.9963942 g/mol |
Monoisotopic Mass | 213.9963942 g/mol |
Topological Polar Surface Area | 138 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 234 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
11
PharmaCompass offers a list of Magnesium Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Magnesium Citrate manufacturer or Magnesium Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Magnesium Citrate manufacturer or Magnesium Citrate supplier.
PharmaCompass also assists you with knowing the Magnesium Citrate API Price utilized in the formulation of products. Magnesium Citrate API Price is not always fixed or binding as the Magnesium Citrate Price is obtained through a variety of data sources. The Magnesium Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Magnesium Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Magnesium Citrate, including repackagers and relabelers. The FDA regulates Magnesium Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Magnesium Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Magnesium Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Magnesium Citrate supplier is an individual or a company that provides Magnesium Citrate active pharmaceutical ingredient (API) or Magnesium Citrate finished formulations upon request. The Magnesium Citrate suppliers may include Magnesium Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Magnesium Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Magnesium Citrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Magnesium Citrate active pharmaceutical ingredient (API) in detail. Different forms of Magnesium Citrate DMFs exist exist since differing nations have different regulations, such as Magnesium Citrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Magnesium Citrate DMF submitted to regulatory agencies in the US is known as a USDMF. Magnesium Citrate USDMF includes data on Magnesium Citrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Magnesium Citrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Magnesium Citrate suppliers with USDMF on PharmaCompass.
A Magnesium Citrate CEP of the European Pharmacopoeia monograph is often referred to as a Magnesium Citrate Certificate of Suitability (COS). The purpose of a Magnesium Citrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Magnesium Citrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Magnesium Citrate to their clients by showing that a Magnesium Citrate CEP has been issued for it. The manufacturer submits a Magnesium Citrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Magnesium Citrate CEP holder for the record. Additionally, the data presented in the Magnesium Citrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Magnesium Citrate DMF.
A Magnesium Citrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Magnesium Citrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Magnesium Citrate suppliers with CEP (COS) on PharmaCompass.
A Magnesium Citrate written confirmation (Magnesium Citrate WC) is an official document issued by a regulatory agency to a Magnesium Citrate manufacturer, verifying that the manufacturing facility of a Magnesium Citrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Magnesium Citrate APIs or Magnesium Citrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Magnesium Citrate WC (written confirmation) as part of the regulatory process.
click here to find a list of Magnesium Citrate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Magnesium Citrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Magnesium Citrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Magnesium Citrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Magnesium Citrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Magnesium Citrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Magnesium Citrate suppliers with NDC on PharmaCompass.
Magnesium Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Magnesium Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Magnesium Citrate GMP manufacturer or Magnesium Citrate GMP API supplier for your needs.
A Magnesium Citrate CoA (Certificate of Analysis) is a formal document that attests to Magnesium Citrate's compliance with Magnesium Citrate specifications and serves as a tool for batch-level quality control.
Magnesium Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Magnesium Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Magnesium Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Magnesium Citrate EP), Magnesium Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Magnesium Citrate USP).